Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood–Brain Barrier
Cells · 2024
DOI: 10.3390/cells13100843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Nuria Seoane und 6 weiteren Autor:innen. Beteiligte Einrichtung: Physiology and Pharmacology of Chronic Diseases (FIFAEC) Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santia…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Nitroprusside, Blood-Brain Barrier, Inflammation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Xunta de Galicia, Deutsch Forschungsgemeinschaft.
Abstract (Originalsprache)
In various neurodegenerative conditions, inflammation plays a significant role in disrupting the blood–brain barrier (BBB), contributing to disease progression. Nitric oxide (NO) emerges as a central regulator of vascular function, with a dual role in inflammation, acting as both a pro- and anti-inflammatory molecule. This study investigates the effects of the NO donor sodium nitroprusside (SNP) in protecting the BBB from lipopolysaccharide (LPS)-induced inflammation, using bEnd.3 endothelial cells as a model system. Additionally, Raw 264.7 macrophages were employed to assess the effects of LPS and SNP on their adhesion to a bEnd.3 cell monolayer. Our results show that LPS treatment induces oxidative stress, activates the JAK2/STAT3 pathway, and increases pro-inflammatory markers. SNP administration effectively mitigates ROS production and IL-6 expression, suggesting a potential anti-inflammatory role. However, SNP did not significantly alter the adhesion of Raw 264.7 cells to bEnd.3 cells induced by LPS, probably because it did not have any effect on ICAM-1 expression, although it reduced VCAM expression. Moreover, SNP did not prevent BBB disruption. This research provides new insights into the role of NO in BBB disruption induced by inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiology and Pharmacology of Chronic Diseases (FIFAEC) Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
- Department of Molecular Pharmacology, University of Groningen, 9713 AV Groningen, The Netherlands.
- Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
ORCID-Profile: Nuria Seoane, Aitor Picos, Martina Schmidt, Amalia Dolga, Manuel Campos-Toimil, Dolores Viña
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Xunta de Galicia
- Deutsch Forschungsgemeinschaft
- Novartis unrestricted grant
- Alzheimer Nederland grant
- Ministerio de Ciencia e Innovación (Spain)
Zitieren
APA
Seoane, N., Picos, A., Moraña-Fernández, S., Schmidt, M., Dolga, A., Campos-Toimil, M., & Viña, D. (2024). Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood–Brain Barrier. Cells. https://doi.org/10.3390/cells13100843
Vancouver
Seoane N, Picos A, Moraña-Fernández S, Schmidt M, Dolga A, Campos-Toimil M, et al. Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood–Brain Barrier. Cells. 2024. doi:10.3390/cells13100843
BibTeX
@article{Seoane2024,
author = {Seoane, Nuria and Picos, Aitor and Moraña-Fernández, Sandra and Schmidt, Martina and Dolga, Amalia and Campos-Toimil, Manuel and Viña, Dolores},
title = {Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood–Brain Barrier},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13100843}
}
EUVIMED